free counter
Health And Medical

App aids self-monitoring of some arthritis rheumatoid patients

App aids self-monitoring of some rheumatoid arthritis patients

Patient-initiated care supported with smartphone self-monitoring is noninferior to usual look after arthritis rheumatoid (RA) in patients with stable low disease activity, in accordance with a report published online July 11 in Arthritis & Rheumatology.

Bart Seppen, M.D., from Reade Rheumatology in Amsterdam, and colleagues assessed the safety and efficacy of a smartphone app for patients with RA, that allows them to self-monitor their disease activity among clinic visits. The analysis included 102 patients randomly assigned to either app-supported patient-initiated care with a scheduled follow-up consultation following a year (app group) or usual care.

The researchers discovered that following a year, noninferiority of the condition activity score 28 (DAS-28) was established with the mean DAS-28 between your groups within the noninferiority limit: 0.04 and only the app group (95 percent confidence interval, 0.39 to 0.30). In the app group, the amount of rheumatologist consultations was significantly lower (visit ratio: 0.62; 95 percent confidence interval, 0.47 to 0.81).

“Our results show that [it] can be done to optimize RA healthcare delivery by letting initiate consultations and self-monitor their disease,” the authors write. “Our may decrease the workforce that’s needed per RA patient and may therefore decrease per patient, which is evaluated in another analysis.”

Copyright 2022 HealthDay. All rights reserved.

Citation: App aids self-monitoring of some arthritis rheumatoid patients (2022, August 12) retrieved 15 August 2022 from

This document is at the mercy of copyright. Aside from any fair dealing for the intended purpose of private study or research, no part could be reproduced minus the written permission. This content is provided for information purposes only.

Read More

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker